Anti-MiRNA-based treatment for hepatocarcinoma intrahepatic metastasis: Monocyte chemotactic protein-1 (MCP-1) suppresses the expression of tumor suppresor CCM1/KRT1 via up regulation of its target gene, 4/July/2014, 6.45 am

Anti-MiRNA-based treatment for hepatocarcinoma intrahepatic metastasis: Monocyte chemotactic protein-1 (MCP-1) suppresses the expression of tumor suppresor CCM1/KRT1 via up regulation of its target gene, 4/July/2014, 6.45 am

Anti-MiRNA-based treatment for hepatocarcinoma intrahepatic metastasis: Monocyte chemotactic protein-1 (MCP-1) suppresses the expression of tumor suppresor CCM1/KRT1 via up regulation of its target gene, 4/July/2014, 6.45 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan PhD

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Citation: Boominathan, L., Anti-MiRNA-based treatment for hepatocarcinoma intrahepatic metastasis: Monocyte chemotactic protein-1 (MCP-1) suppresses the expression of tumor suppresor CCM1/KRT1 via up regulation of its target gene, 4/July/2014, 6.45 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

* Research cooperation

Share
Start Typing